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A Novel Approach to Decrease Cutaneous Depigmentation
Almost all of the cutaneous disorders that have an in¯ammatory
component, including most common dermatoses like acne and
eczema, may lead to cutaneous hyperpigmentation. In addition,
hyperpigmentation is observed in connection with estrogen plus
progestational agents that are prevalent during pregnancy or in birth
control pills. Such pigmentary changes leave unsightly spots, which
may take years to fade and are most prominent in individuals with
darker skin coloration. Therapeutic management of hyperpigmen-
tary disorders is far from satisfactory. Treatment options include the
application of bleaching creams containing hydroquinone, treti-
noin, glycolic acid, azelaic acid, kojic acid, buthionine sulfoximine,
cystamine, and Jessner's solution. Laser therapy has limited success
and carries the risk of additional postin¯ammatory hyperpigmenta-
tion. Two distinct components participate in epidermal pigmenta-
tion: melanocytes cells that produce melanin and package it in
melanosomes, and keratinocytes that take up the fully pigmented
melanosomes, and the latter eventually disperse in the keratino-
cytes. The biologic processes involved in melanosome transfer are
not well elucidated. Still, several investigators have reported that
melanosome-transfer is the result of phagocytosis of the tips of
melanocyte dendrites by surrounding keratinocytes. Interestingly, it
was recently reported that the protease±activated receptor 2 (PAR-
2), a novel G protein regulated receptor that is expressed on
keratinocytes, participates in cutaneous pigmentation by enhancing
keratinocyte phagocytosis and increasing melanosome transfer.
PAR-2 belongs to a family of receptors that carry their ligand in
their amino-terminus domain. Protease activity unmasks the
tethered ligand by cleaving off an amino-terminal exodomain,
allowing the ligand to bind onto the body of the receptor and to
initiate signaling. Trypsin and mast cell tryptase are two proteases
that activate PAR-2. In this issue, Paine et al. (p. 587) investigated
the capability of two protease inhibitors isolated from soybean milk,
to inhibit PAR-2 activation and decrease melanosome transfer. The
authors report that soymilk as well as the Kunitz-type trypsin
inhibitor and the Bowman-Birk protease inhibitor decreased
pigmentation both in vitro in keratinocyte-melanocyte cocultures
and in vivo in dark skinned Yucatan microswine and African-
American skin transplanted into SCID mice. The authors show that
the decreased pigmentation is due to decreased keratinocyte
phagocytosis of melanosomes and inhibition of PAR-2 activation.
Furthermore, in Yucatan microswines the preparations also
inhibited UV-induced pigmentation. The effect of treatment was
reversible and did not appear to have adverse effects on the
epidermis as determined by histologic criteria. Treatment with
PAR-2 inhibitors could prove to be an effective method for
decreasing constitutive cutaneous pigmentation and a novel
therapeutic modality for treating at least the epidermal component
of a variety of cutaneous disorders characterized by hyperpigmen-
tation.
Vascular Endothelial Growth Factor Induces its Own Expression in Dermal Microvascular Endothelial Cells
Vascular endothelial growth factor (VEGF) is a potent endothelial
cell mitogen promoting their proliferation and migration. In
addition, VEGF affects the formation of capillary tubules and also
acts as a proin¯ammatory cytokine by increasing vascular perme-
ability and inducing adhesion molecules on endothelial cells,
enhancing their leukocyte binding potential. VEGF is produced by
normal as well as by malignant cells and VEGF gene transcripts
have been identi®ed in many adult organs. In skin, a variety of
growth factors and cytokines induce VEGF in keratinocytes and
tissue hypoxia induces VEGF expression in keratinocytes and
®broblasts. Interestingly, hypoxia and TPA treatment induce VEGF
synthesis in dermal microvascular endothelial cells. VEGF is a
homodimeric protein of 36±46 kDa molecular weight and different
isoforms are generated by alternative splicing of the original
mRNA transcript. Human epidermal keratinocytes synthesize the
three major spliced forms of VEGF, namely the 189, 165 and 121
amino acids isoforms. The 121 and 165 amino acid isoforms are
secreted, whereas the 189 isoform remains associated with the cell.
VEGF has four identi®ed receptors: VEGF receptor 1 (Flt-1) and
VEGF receptor 2 (Flk-1/KDR), two transmembrane tyrosine
kinase receptors, and nontyrosine kinase receptors, neuropiline-1
and ±2. It was recently proposed that KDR activation plays a
dominant role in endothelial cell proliferation promoting angio-
genesis, whereas the role of Flt-1 is primarily to antagonize the
interaction of VEGF with KDR. The role of neuropilin in VEGF
signalling is still being investigated. In this issue Vega-Diaz et al. (p.
525) show that stimulation with VEGF transactivates human VEGF
promoter and induces VEGF expression in human dermal
microvascular endothelial cells. This induction requires MAP
kinase activation. Furthermore, using radioimmunoassay and
antibodies speci®c for the mature 121 and 165 VEGF isoforms,
the authors show that these isoforms are synthesized in the cells.
Moreover, using anti-KDR and anti-Flt-1 antibodies the authors
show that in response to VEGF, VEGF mRNA induction is
mediated by the dominant KDR and not by the stationary Flt-1.
The authors suggest that such autocrine loop, in which VEGF
activates its own transcription, could play an important role in
cutaneous angiogenesis.
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Endothelin Plays a Role in Solar Lentigo
Endothelins are a family of vasoconstrictor peptides composed of 21
amino acids. Three mammalian endothelins have been described:
endothelin 1, 2 and 3. The three endothelins bind to two subtypes
of endothelin receptors, endothelin receptor A and endothelin
receptor B. Both receptors are members of the G-protein family of
transmembrane receptors. Vascular endothelial cells produce
endothelins as well as a variety of other cell types, including
neurons, epithelial cells, and keratinocytes. It has been shown that
melanocytes express the high-af®nity receptor for endothelin-1,
endothelin B receptor, and that endothelin-1 is mitogenic for
melanocytes, enhances melanogenesis by stimulating tyrosinase
activity, and promotes melanocyte dendricity. Interestingly,
endothelin-1 production by keratinocytes is increased after UV
irradiation, suggesting that endothelin-1 mediates, at least in part,
UV-induced pigmentation as well as melanocyte dendricity and
proliferation. The role of endothelins in other UV-associated
cutaneous pigmentary changes, however, had not been addressed to
date. In this issue Kadono et al. (p. 571) provide evidence that
implicates endothelin-1 in the evolution of solar lentigo (senile
lentigo). Kondo et al. show that endothelin-1 expression and level is
increased in keratinocytes of solar lentigo as compared with
keratinocytes in perilesional skin. Not surprisingly, tyrosinase
expression is also upregulated in lesional skin as well as the
expression of endothelin receptor B. Although the latter has been
reported to be expressed by keratinocytes in addition to
melanocytes, the authors argue that because the levels of endothelin
receptor B in keratinocytes are low, the increased expression of this
receptor indicates upregulation in melanocytes. Thus, they
demonstrate a coordinated increase in the receptor and its ligand
in lesions of solar lentigo. To further elucidate the mechanisms that
participate in endothelin-1 upregulation in lesions of solar lentigo,
the authors examined the expression and level of two cytokines that
are known to induce endothelin-1 in cultured keratinocytes, TNF-
a and IL-1a. The levels of TNF-a mRNA and protein were
increased whereas the levels of IL-1a mRNA and protein were
decreased in lesional skin. Although it is possible that endothelin-1
induction in lesions of solar lentigo is mediated through TNF-a,
investigations using a larger number of donors are required to draw
this conclusion. Finally, the authors examined the expression of
endothelin-converting enzyme that regulates endothelin-1 secre-
tion, but found no modulation in the expression of the enzyme
between lesional and perilesional skin. Endothelins play an
important role in fetal melanocyte development. This work
suggests that endothelins may also play a role in pathologic
conditions of the adult organism.
PTCH, UV, and SCC
This study complements the observations that the development of
squamous cell carcinoma (SCC) in human skin is tightly linked to
UV exposure. Whereas it has been known for a long time that the
majority of SCC contain mutations in the tumor suppressor gene
p53, mutations in other genes, such as PTCH, have not convin-
cingly been shown. In this article, Ping et al. (p. 614) report that
some of the observed nucleotide changes in the PTCH gene
represent UV-signature mutations, as is also true for the majority of
the p53 mutations found in SCC. Because the described mutations
occur only in a subset of SCC tested, however, in particular in
those individuals that present a history of multiple basal cell
carcinomas (BCC), it will be interesting to investigate whether such
individuals bear a speci®c susceptibility to UV-induced mutations
other than skin type, for example. One day, screening might allow
identi®cation of those individuals who are at a higher risk for
developing SCC and BCC and may allow early preventive and
diagnostic measures.
UVB Induces Melanogenesis Through Stem Cell Factor/C-Kit Signaling
The presented ®ndings in this work add another valuable piece of
information to the understanding of the complex interactions
between keratinocytes and melanocytes in UV-induced melano-
genesis. It has been suggested in previous reports that stem cell
factor (SCF) and its receptor c-kit play an important role in the
migration of melanoblasts from the neural crest to the epidermis,
and that SCF/c-kit are involved in the development of human
melanocytes. In this issue, Hachiya et al. (p. 578) provide evidence
that SCF/c-kit signaling plays a role in UV-induced tanning.
Exposure of human keratinocytes and melanocytes in vitro, as well
as human epidermis in vivo, to UVB irradiation leads to
upregulation of transcription and protein levels of SCF in
keratinocytes and c-kit in melanocytes. Subepidermal injection of
c-kit blocking antibodies abolishes the UVB-induced pigmentation
in vivo, at least in part, by inhibiting melanocyte activation, as
shown by a lack of increase in DOPA-positive melanocytes. Better
understanding of the fundamental mechanisms involved in
melanogenesis might help in the development of new therapeutic
strategies for pigmentary disorders of the skin.
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